Open Access

Designer nanoparticle: nanobiotechnology tool for cell biology

Nano Convergence20163:22

DOI: 10.1186/s40580-016-0082-x

Received: 26 April 2016

Accepted: 29 August 2016

Published: 15 September 2016


This article discusses the use of nanotechnology for subcellular compartment isolation and its application towards subcellular omics. This technology review significantly contributes to our understanding on use of nanotechnology for subcellular systems biology. Here we elaborate nanobiotechnology approach of using superparamagnetic nanoparticles (SPMNPs) optimized with different surface coatings for subcellular organelle isolation. Using pulse-chase approach, we review that SPMNPs interacted differently with the cell depending on its surface functionalization. The article focuses on the use of functionalized-SPMNPs as a nanobiotechnology tool to isolate high quality (both purity and yield) plasma membranes and endosomes or lysosomes. Such nanobiotechnology tool can be applied in generating subcellular compartment inventories. As a future perspective, this strategy could be applied in areas such as immunology, cancer and stem cell research.


Nanoparticles Subcellular proteomics Nanobiotechnology Systems biology

1 Background

Nanotechnology is defined as molecular engineering of functional systems for generating high performance technologies for both research and industry [1, 2]. Specifically, use of molecular engineering of biological systems resulted in emergence of Nanobiotechnology [3]. Some of the nanobiotechnology applications include (a) nanoscopy for bio imaging [47]; (b) nanoparticle for subcellular fractionation [8]; (c) nanoparticle for drug delivery, vaccine [9]; (d) nanoparticle for cancer therapy by hyperthermia [10]; (e) nanomaterials for tissue engineering and artificial/synthetic organ generation [11]; (f) nanotechnology for cell tracking [12, 13]; and (g) nanotechnology for large-scale data generation [14]. Particularly, use of nanotechnology in generating subcellular omics is less studied and understood. This article focuses on nanobiotechnology strategy for organelle isolation and also deciphers innovative approaches for omics analysis. Using physical properties, its nanoparticle-cell interaction and endocytosis machinery, we propose the nanobiotechnology strategy that has robust advantages in isolating subcellular compartments [15]. Due to such advantages, it is possible to isolate subcellular compartments in native and physiological conditions. In this article, we also case study the impact of nano-biotechnology tool for subcellular omics analysis.

2 Subcellular omics

To generate subcellular omics datasets, it is essential to understand the locality and functional activity of proteins in given eukaryotic cell [16]. It is well-known that proteins are spatially distributed and localized function [17]. It has been reported that majority of the mature glycosylated protein (for example: Nicastrin) are present in post-Golgi compartments like plasma membrane, endosomes or lysosome and immature glycosylated protein are present in the pre-Golgi compartments [18]. Similarly, cholesterol is predominately present in the cell membrane at the level of 90 % of the total cholesterol level in cell extract [19]. While performing proteomics or lipidomics in total cell extract or single cell omics, there is a high possibility of reduced spatial and localized distribution of proteins and lipids in any given cell. This has led to a major interest for subcellular omics such as plasma membrane and endosomal compartments like endosomes and lysosomes [20]. This is due to several scientific findings which confirm that the majority of protein functional activity and substrate cleavage occurs at cell surface and endosomal compartments (Table 1) [21]. Similarly by isolating plasma membrane or endosomes, it is possible to generate proteomics, glycomics and lipidomics for these organelles [22]. By compiling obtained omics (proteomics, glycomics, and lipidomics), for different organelles, comprehensive whole cell omics can be generated both under native and altered conditions [2326]. The key factor for generating comprehensive omics datasets s is to isolate subcellular compartments with high purity and yield. Several types of fractionation methodologies have been applied for organelle isolation for subcellular omics analysis. In the technology review, we elaborate advantages among different subcellular compartmental isolation and how nanobiotechnology strategy is superior in isolating plasma membrane and endosomes as in Tables 2 and 3.
Table 1

List of subcellular organelles and their functions

Subcellular Organelles

Isolation techniques

Cell wall

Gradient centrifugation


Gradient centrifugation antibody based pull-down assay, SPMNPS: Tag-anti-tag; Antibody conjugated; Biotin-streptavidin

Cilia and flagella

Gradient centrifugation Antibody based pull-down assay; Tag-anti-tag; Antibody conjugated; Biotin-streptavidin


Gradient centrifugation antibody based pull-down assay; Tag-anti-tagged; Antibody conjugated; Biotin-streptavidin tagged SPMNPs


Gradient centrifugation antibody based pull-down assay; Tag-anti-tagged; Antibody conjugated; Biotin-streptavidin SPMNPs

Early endosomes

Gradient centrifugation SPMNP isolation assay antibody based pull-down assay; Biotin-streptavidin tagged SPMNPs; antibody-SPMNPs; Negatively charged lipid-SPMNPs

Endoplasmic reticulum (ER)—rough or smooth

Gradient centrifugation antibody based pull-down assay; Tag-anti-tag; Antibody conjugated; Biotin-streptavidin tagged SPMNPs

Golgi apparatus

Gradient centrifugation antibody based pull-down assay; Tag-anti-tagged; Antibody conjugated; Biotin-streptavidin tagged SPMNPs

Late endosomes

Gradient centrifugation SPMNP isolation assay; Biotin-streptavidin; antibody-SPMNPs; Negatively charged SPMNPs

Multi-vesicular bodies

Gradient centrifugation SPMNP isolation assay; antibody based pull-down assay; Biotin-streptavidin; antibody-SPMNPs


Gradient centrifugation antibody based pull-down assay; Tag-anti-tagged; Antibody conjugated; Biotin-streptavidin


Gradient centrifugation antibody based pull-down assay; Tag-anti-tagged; Antibody conjugated; Biotin-streptavidin tagged SPMNPs


Gradient centrifugation SPMNP isolation assay Antibody based pull-down assay; Biotin-streptavidin; antibody SPMNPs


Gradient centrifugation SPMNP isolation assay Antibody based pull-down assay; Biotin-streptavidin tagged SPMNPs; antibody

Plasma Membrane or Cell Membrane

Gradient centrifugation; Cationic silica beads; SPMNP isolation; antibody conjugated; Biotin-Streptavidin; lectin–SPMNPs


Gradient centrifugation; pull -down assay; anti-S10/anti–EF-Tu-SPMNPs; Biotin-streptavidin; antibody- SPMNPs

Lipid rafts

Gradient centrifugation antibody based pull-down assay; Tag-antitagged-SPMNPs; Biotin-streptavidin; protein conjugated magnetic isolation

Secretory granules or vesicles

Gradient centrifugation antibody based pull-down assay; Tag-antitagged SPMNPs; Biotin-streptavidin-SPMNPs


Gradient centrifugation antibody based pull-down assay; Tag-anti-tag SPMNPs; Antibody conjugated; Biotin-streptavidin SPMNPs


Gradient centrifugation; antibody based pull-down assay; antibody conjugated magnetic nanoparticles


Gradient centrifugation; pull-down assay; antibody conjugated SPMNPs; Tag-anti-tagged; Antibody conjugated; Biotin-streptavidin; Anti-TOM22 antibody tagged SPMNPs

Table 2

Comparison of existing technologies for plasma membrane isolation

Isolation methodologies



Density Gradient Centrifugation

Conventional method that can be used to isolate plasma membrane along with other subcellular compartments

Effective method to isolate lysosomes from tissue or in vivo cell fractions

Simple procedure that can be performed using an ultracentrifuge

Low yield and low purity

Cannot isolate intact membrane layers

Not efficient for isolating cell membrane lipids and for performing functional studies

Cationic silica based isolation

Classical method used to isolate cell membrane layers with high purity

Generic method used to isolate cell membrane from tissue, in vitro and in vivo

Formation of matrix by the use of polylysine crosslinker helps in the isolation of membrane layers without any breakage

Low yield

Isolates only available membrane layer i:e only 50 % of cell surface of adherent cells grown on a petri dish

Not robust to perform lipidomics, glycomics and native condition experiments

Cell Surface biotinylation based pull-down assay

Generic method that targets cell surface lysine residue

Can be used in combination with magnetic or non-magnetic beads

Can be used in combination to isolate endosomal compartments

Can isolate only available membrane layer i:e only 50 % of cell surface of adherent cells growing on a petri dish

Technology has not been established to isolate cell membrane from cell suspension

Requires detergent in fractionations

Antibody conjugated magnetic nanoparticle based pulldown assay

Can be used to pull down proteins after post-fractionation

Can also be used to target selective micro-domains

Can be used in combination with biotin-streptavidin assay

Isolates only available membrane layer (only 50 % surface of adherent cells on a petri dish

Technology has not been established to isolate cell membrane from cell suspension

requires detergent in fractionations

SPMNPs based plasma membrane isolation;

A novel strategy that is generic for any kind of cell systems

Method does not involve use of detergent or antibody that affects the nativity of membranes

Method can also use targeted plasma membrane micro-domain by using ligand-tagging

Can be used to isolate protein under native conditions which can hence be used for functional studies

Can isolate cell membrane lipids

Can perform, first of its kind, cell membrane glycosylation

High yield and high purity

Can be used in combination with endosomal isolations

Technology has not be established for tissue cell membrane isolation and in vivo experiments

Isolates only available membrane layer (only 50 % surface of adherent cells on a petri dish

Technology has not been established to isolate cell membrane from cell suspension. Possibility exists to use this technology for cells in suspension culture

Table 3

Comparison of existing technologies for endosomes and lysosome isolation

Isolation methodologies



Density gradient centrifugation;

Conventional method that can be used to isolate endosomes and lysosomes along other subcellular compartments

Effective method to isolate lysosomes from tissue or in vivo cell fractions

Simple procedure that can be performed using an ultracentrifuge

Low yield

Difficulties in separating endosomes from lysosome vesicles

Difficulties in separating different endosomal and its associated vesicles

Antibody based pull-down assay

Can be used to pull down proteins after post-fractionation

Can also be used to target selective endocytic uptakes

Can be used in combination with biotin-streptavidin assay

Limited applicability for certain endocytosis uptake

Limited yield and low purity

Cannot isolate vesicles under native conditions

SPMNPs based isolation;

A novel strategy that is generic for any kind of cell systems with reasonable purity and yield

Method does not involve the use of detergent or antibody that affects native conditions

Method can also use targeted endosomal uptake pathway by using ligand tagged nanoparticle

Can be used to isolate protein under native conditions and all endosomal uptake

Technology has not be established for isolation of vesicles form tissue cells and in vivo experiments

Technology has not been established to isolate vesicles from cell suspension. Possibility exists to use this technology for cells in suspension culture

3 Technology review

3.1 Organelle fractionation and subcellular compartmental isolation

The governing factor for organelle fractionation is high yield and high purity (Fig. 1). Most commonly used methodology is density-gradient centrifugation (sucrose-based fractionation). This method is based on principle of differential (density) equilibrium or non-equilibrium based centrifugation for organelle separation [27, 28]. Other commonly used fractionation is antibody based pulldown assay. This assay makes use of magnetic beads that are tagged with antibodies selectively targeting the subcellular compartments [29]. An example is the use of TOM22 antibodies conjugated with magnetic beads for mitochondria isolation [30, 31]. This principle is also used for post-nanoparticle labeling based fractionation. Here, organelle-specific antibody conjugated nanoparticles are used to target fractionated subcellular compartment. This technique is largely used in isolating compartments that are larger in size and less dynamic or more static such as ER, Golgi, nucleus, mitochondria and lysosomes [32]. However, the applicability of this technique is limited as it cannot be used to isolate intact cell membrane. Many methods have used charge based affinity to isolate eukaryotic cell membrane [33]. The cell membrane is negatively charged due to presence of anionic components such as proteins, lipids and carbohydrates. Hence, conventional method such as cationic latex or silica beads is used for isolating cell membrane. By using poly-lysine for crosslinking silica beads, cell membranes are isolated as cross-linked membrane layers which are disadvantage for performing functional studies [34]. An alternative method that has been used is biotin-streptavidin affinity fractionation. The main principle behind biotin-streptavidin affinity assay is based on selective binding of available lysine residues on cell surface protein by biotin molecule which is further captured by streptavidin [35]. These streptavidin tagged micro beads or magnetic beads are used to pull down cell membrane protein or protein complexes from cell fractionation. By using pulse-chase method (elaborated in the later part of the paper), biotin-streptavidin affinity can be used to isolate early, intermediate and late endosomal compartments [36]. Recently, nanoparticle based fractionation has emerged as the strategy to isolate dynamic subcellular compartments like cell membrane, endosomes and lysosome by using endocytosis machinery.
Fig. 1

Subcellular compartments and specific purification methodology

There are different categories of endocytosis (Fig. 2). One of the main subsets is phagocytosis that mainly involves cellular uptake of beads of size 1–100 microns using phagosome [37, 38]. Another strategy is use of pinocytosis which is further classified into (1) micropinocytosis (<1 micron) [39]; (2) clathrin-mediated pinocytosis: size ~120 nm by clathrin mediated receptor-ligand induced cellular uptake [40]; (3) caveolin-mediated pinocytosis: is cellular uptake that uses caveolin and lipid rafts in endosomal assembly with size of 20–60 nm [41]; and (4) caveolin and clathrin independent endocytosis (<90 nm) that is independent of clathrin and caveolin but includes ARF6 [42]. In macropinocytosis, there is non-specific cellular uptake, which is mainly utilized by several nanoparticles–cell interactions [43]. In clathrin mediated endocytosis, ligand coupled nanoparticle endocytosis through receptor mediated uptake mechanism [44, 45]. While for caveolin mediated endocytosis, targeting caveolin1/2 or lipid raft associated protein flotilin-1 with the specific antibody tagged nanoparticle is the commonly used approach [46]. However, when clathrin mediated endocytosis was blocked using sucrose, nanoparticle uptake was not limited, and thereby showing that there is size dependent cellular uptake of nanoparticle via caveolin mediated endocytosis [47]. Nevertheless it is clear that surface coating and size of the nanoparticle are governing factors for selective endocytosis and cellular uptake.
Fig. 2

Endocytosis pathway

4 Nanoparticle synthesis

The surface functionalization, size, physical properties and endocytosis machinery of nanoparticle are key factors for nanobiotechnology strategy. The physical properties are dependent on the type of core–shell material [48, 49]. It is possible to govern the magnetic properties of the nanoparticle by using iron oxide or cobalt-iron oxide as a core. Here superparamagnetic properties can be achieved when nanomaterial is of size <30 nm [50]. Shell material (surface coating) which acts as an interface between core and biological environment governs the use of nanoparticle for different biological applications. Nanoparticles that are synthesized in organic phase tend to be water insoluble. They require an additional step of exchange with water soluble ligands for biological applications. Commonly used methods for synthesizing nanoparticle are (a) chemical precipitation method and (b) thermal decomposition method [51]. Thermal decomposition method is preferred for its high monodispersity (in terms of its size) and high quality yield. However, it requires additional step for water-soluble ligand exchange or addition [52, 53] (Fig. 3). Further, functionalized nanoparticle can be used for ligand coupling and bioconjugation using the free end-groups like NH2, COOH and -SH.
Fig. 3

Manufacturing of water-soluble superparamagnetic nanoparticles

5 Bioconjugation strategy for subcellular interaction

Surface functionalization of nanoparticle determines the kinetics behind nanoparticle-cellular uptake. Depending on the surface coating, nanoparticle can be ± charged which is determined by the presence of NH2 and COOH respectively. Addition of PEG group in supports biocompatibility [54] and the nanoparticle can be further functionalized by coupling with the endgroup (Fig. 4). By tagging fluorescent ligand, it is possible to perform live cell imaging and nanoparticle tracking for studying the receptor-ligand and nanoparticle-cell interaction. Depending on the target, an appropriate ligand can be selected and conjugated to the nanoparticle [55]. Ligand size and shape determines the surface area to volume ratio which is the governing factor for nanoparticle functionalization [56]. Another key factor is ligand selection. Ligand selection depends—(a) receptor that can be well internalized (for cellular trafficking); b) 1:1 ratio of ligand: nanoparticle to avoid nanoparticle crosslinking. Here we illustrate three strategies for bioconjugation of SPMNPs that are functionalized with lipids, DMSA, TMAOH (Fig. 5). First approach is to use monovalent avidin and target biotinylated protein. Second approach proposes the conjugation of FIAsH-EDT2 with SPMNPs. FIAsH-EDT2 coupled SPMNPs are used to couple tetra-cysteine containing motif proteins [57]. Third approach is to conjugate SPMNPs with DOGS-NTA-Ni (II) in order to anchor histidine-tagged protein. However, major limitation for bioconjugation is nanoparticle aggregation due to coupling reagent like glutaraldehyde. Although glutaraldehyde works very well for protein conjugation and crosslinking, there are tendency for reagent to result in multiple layer crosslinking among nanoparticles due to non-specific interaction and competitive affinity. Such multilayer crosslinking results in increase of size and change in physical properties, thereby affecting organelle isolation. Hence some key guidelines to be considered during bioconjugation of nanoparticles are (1) retaining size and stability of nanoparticle; (2) performing sequential bioconjugation; (3) implementing biocompatible surface functionalization; and (4) finally, a strategy that monitors protein association/disassociation with the nanoparticle.
Fig. 4

Nanoparticle-cell interaction

Fig. 5

Bioconjugation strategy for nanoparticle

6 Pulse-chase methodology

Pulse-chase methodology is a commonly used approach to study the mechanism of endocytosis. Generally, pulse-chase strategy for omics analysis includes five stages or phases wherein Phase-I: includes generation of water-soluble nanoparticle by existing (thermal decomposition or chemical precipitation) synthesis and quality control using characterization; Phase II: includes selective bioconjugation of nanoparticle for a selective pathway-specific cellular uptake. For such pathway-specific cellular uptake, protein/ligand/synthetic peptide is used for receptor mediated endocytosis and charge dependent shell uptake is used for receptor independent endocytosis. Phase III: Pulse-Chase methodology is used to optimize pulse and chase period to selectively localize nanoparticle in vesicle. Phase IV: Magnetic separation strategy is used for subcellular compartmental enrichment along with ultracentrifugation. Phase V: Endosomal proteome using Mass Spectrometry analysis. This pulse-chase strategy was commonly used in radioactive labeling in the cell and this technique has now been extended to nanoparticle based subcellular compartmental isolation (Fig. 6). Briefly, pulse-chase strategy is used to govern receptor-mediated endocytosis of nanoparticle-ligand complex and has recently been extended to other endocytosis mechanisms [58]. During pulse period, nanoparticle is incubated with cells at 37 °C or at 4 °C for a certain period of time (0–1 h.) in the presence of medium. Depending on the application, nanoparticle with appropriate concentration is incubated in PBS or culture medium at 4 °C (for non-chase conditions) and 37 °C (for chase conditions). This time frame allows nanoparticle to interact with the cell surface and its protein. Depending on the dynamics and kinetics of nanoparticle-ligand interaction, pulse incubation involves a time period in the range of 10 min to 1 h. For example, if it is for cell membrane or plasma membrane isolation, the nanoparticle is incubated at 4 °C for 15–20 min in PBS with the adherent cells. Depending on whether the cells are adherent or in suspension, or it is receptor mediated or charge mediated, there is variation in the pulse time period required for cellular uptake [59]. After pulse period is performed, the chase is incubated at appropriate time period depending on the compartmental isolation. Chase period represents the time where the nanoparticle containing medium is replaced with fresh medium without nanoparticle. This supports streamlining nanoparticle internalization in the cell and accumulation of nanoparticle into a certain compartment of interest depending on the timeframe. For endosomal isolation, chase period is generally for a timeframe of 10–15 min. For late endosomes, chase period is generally for 15–20 min and for lysosomes it is more than 30 min. However since endocytosis is dynamic in mechanism, it is relatively difficult to isolate highly pure early and late endosomes (Fig. 7). At the same time it is possible to isolate highly pure lysosome by performing a chase period of more than 3 h and up to 24 h. This is mainly because lysosome is the endpoint for most of the endocytosis [60]. For targeting, phagosome or autophagosome, chase period is adjusted accordingly for 30–60 min before phagosome fuses to lysosome. Nanoparticle can be concentrated in lysosome after 60 min of chase period. An advantage of using chase period is that it provides useful information for nanoparticle tracking. For this reason, fluorescence tagged nanoparticle is used for pulse–chase methodology and live-cell imaging [61]. By incubating with endocytic inhibitors for endosomal or lysosomal fusion, it is possible to limit the nanoparticle-cellular internalization and subcellular trafficking. For example, by limiting the endosome-lysosomal fusion using Latrunculin-A, it is possible to concentrate the nanoparticle in early or late endosomes [62]. It is also reported that the nanoparticle coupled ligand does not mimic the ligand cellular uptake and subcellular compartment localization. Few examples in the later part of this article elaborate on the deviation in cellular uptake. These examples are confirmed by using pulse-chase methodology, magnetic organelle isolation and live cell imaging using fluorescence tag [63]. For optimal use of pulse-chase method, it is important to establish a methodology for specific subcellular compartments. Here, we describe two interesting nanoparticle based methodologies to isolate plasma membrane and endosomal compartments using affinity purification.
Fig. 6

Step by step approach toward subcellular compartmental proteomics

Fig. 7

Pulse-chase methodology

7 Nanoparticle based novel method for plasma membrane affinity purification

Figure 8 represents the step-by-step strategy to isolate plasma membrane using nanoparticle based affinity purification. Briefly, SPMNPs coated with positively charged NH2 functionalized PEGylated lipids are incubated with adherent cells grown in a 10 cm dish or a 75 cm2 flasks. The time period of incubation is generally 15 to 20 min at 4 °C in PBS with horizontal shaking such that it doesn’t detach the cells. (Note: An additional step of incubating adherent cells at 4 °C for 30 min before nanoparticle-cell interaction is recommended). After incubation, the nanoparticle containing supernatant is removed and washed twice with fresh ice-cold PBS. Cells are removed from the dish/flask by scrapping the cells. Detachment of cells using trypsin is not recommended as it might affect cell surface proteins which this method aims to isolate. Cell suspension is further homogenized using a homogenizing apparatus and buffers that maintain physiological conditions. Further, nuclear fraction and unbroken cells are separated from post nuclear fraction by centrifuging at 800 rpm for 10 min at 4 °C. The post nuclear fraction is passed through the magnetic field. Here, the unbound fraction is eluted while the magnetic fraction is further washed with 1 M potassium chloride and 0.1 M sodium carbonate solution in the presence of magnetic field. An additional washing step with homogenizing buffer can be included to further clear the unbound material. 1 M KCl and 0.1 M Na2CO3 solution are used to remove cytoskeleton-associated compartments from the cell surface proteins. Further, the magnetic field is removed and bound fraction is eluted from the column. Finally the bound fraction is enriched by pelleting at 50,000 rpm for 1 h. The pellet is resuspended in an appropriate amount of PBS for further analysis like mass spectrometry.
Fig. 8

Strategy towards Plasma Membrane isolation

8 Nanoparticle based novel method for endosomes and lysosomal affinity purification

Figure 9 represents another step-by-step strategy to isolate endosomes and lysosomes using nanoparticle based affinity purification. Briefly, DMSA or TMAOH or Silane coated nanoparticles are incubated with adherent cells that are grown in 10 cm dishes. The pulse time period is generally 15 to 20 min at 37 °C in medium with horizontal shaking such that it doesn’t detach the cells. After incubation, the SPMNPs containing medium is removed, washed twice with fresh medium and incubated for the chase period (0–24 h) with fresh medium. Cells are then removed from the dish/flask by scraping. Cell suspension is further homogenized as explained in the previous section. Further, nuclear fraction and unbroken cells are pelleted at 800 rpm for 10 min at 4 °C. The post nuclear fraction is passed on the column in presence of magnetic field. Here, unbound fraction is eluted while the magnetic fraction is further washed with the homogenizing buffer to further clear unbound material. This is followed by the removal of magnetic field and elution of the bound fraction from the column. Finally the bound fraction is enriched by pelleting at 50,000 rpm for 1 h. The pellet is resuspended in PBS for further analysis. Based on chase, the subcellular localization of nanoparticles can be determined as illustrated Early (~10 min), Late (~20 min) and Lysosomes (>30 min) [57, 58, 6468].
Fig. 9

Strategy towards endosomal isolation

Although nanoparticle-protein complex can be used for endosomal trafficking and for proteomics, there are illustrations, which show that nanoparticle-protein complexes are trafficked differently compared to the target protein complex. For example, trafficking of ricin conjugated nanoparticle is reported to be unlike the ricin ligand where trafficking occurs from early endosomes (EE), trans-Golgi network (TGN) and finally to endoplasmic reticulum (ER). It is well known that transferrin is recycled to the cell surface via recycling endosomal compartments such as recycling endosome via early endosomes and multi-vesicular bodies. However, transferrin conjugated nanoparticle and Shiga toxin (ricin) conjugated nanoparticle are shown to traffic from early endosomes to late endosomes and finally accumulated at lysosomes. It is also reported the Shiga toxin conjugated nanoparticle tend to accumulate at early endosomes while Shiga toxin traffic like ricin (from EE to TGN and finally to ER).

9 Conclusion

Tables 2 and 3 list the commonly used techniques for subcellular isolation of plasma membrane and lysosomes with high purity and yield. Both tables show that nanoparticle based methods hold many advantages as compared to existing methods. Using the isolation technology, several omics datasets for subcellular compartments can be generated for any given cell. There is an interesting aspect in the use of nanoparticle based method that is generic in nature. Hence, the method can be applied to wild-type and diseased cell-type (for example cancer cell) for plasma membrane and endosomal compartmental isolation. By using the nanoparticle based subcellular compartmental isolation; one could potentially generate a complete and comprehensive plasma membrane or endosome or lysosome proteomics, glycomics and lipidomics for any cell type. By the generated subcellular omics, nanobiotechnology can serve as a useful tool to build omics datasets for cancer biology using the bottom-up pyramid approach. Using the bottom-up pyramid approach in omics analysis, subcellular omics datasets (including genomics, proteomics, lipidomics and glycomics) can be compiled together and compared with the whole cell omics analysis. This approach can also be used to generate several omics datasets in cancer biology that can enable the researchers to revisit the subcellular omics in order to understand the biological significance and functional relevance. For all such omics analysis studies, it is necessary to have an efficient, robust and high precision technology for subcellular compartmental isolation. The technology also needs optimization and fine tuning depending on its applicability with host cell system. Using different nanobiotechnology tools for subcellular compartmental isolation, several high-throughput functional omics dataset like fluxomics, metabolomics, interactomics and localizomics can be generated. Using all these datasets, comprehensive Phenome and subcellular omics are generated that can by analyzed using nanotechnology for data storage studies. Further dataset thus gets larger for different diseases such as cancer, diabetes, infectious diseases, ageing related diseases, and neurodegenerative diseases. These dataset and nanotechnology based analytics can be used in drug development, pre-clinical studies, patent analytics, and other applications. As a future perspective, the use of nanoparticle as nanobiotechnology tool is all set to be a game changer in the generation of Datasets for systems biology.


Authors’ contributions

DBTGR and NAK designed, and wrote the manuscript. Both authors read and approved the final manuscript.


Figures are made through Servier Medical Art ( The author thanks funding from the Not for Profit firms Envirotransgene™ Biosolutions Global and Deepak Thimiri Consulting Group (DTCG™) Grenoble, France/Chennai, India.

Competing interests

The authors declare that they have no competing interests. Deepak B. Thimiri Govinda Raj is an inventor of Plasma membrane isolation patent and consultant for Envirotransgene™ Biosolutions.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

European Molecular Biology Laboratory (EMBL), Grenoble Outstation and Unit of Virus Host-Cell Interactions (UVHCI), UJF-EMBL-CNRS
Envirotransgene Bio-solutions Global
Biotechnology Centre for Oslo, Centre for Molecular Medicine Norway (NCMM)
Laboratory of Lipid Metabolism and Cancer


  1. Robert Lee, Elen Stokes, Twenty-first century novel: regulating nanotechnologies. J. Environ. Law. 21(3), 469–482 (2009)View ArticleGoogle Scholar
  2. R. Chau, S. Datta et al., Benchmarking nanotechnology for high-performance and low-power logic transistor applications. IEEE Trans. Nanotechnol. 4(2), 153–158 (2005)View ArticleGoogle Scholar
  3. Ehud Gazit, Plenty of room for biology at the bottom: an introduction to bionanotechnology (Aviv University, Israel, 2007). ISBN: 978-1-84816-930-2View ArticleGoogle Scholar
  4. Y. Zhang et al., Nanobiotechnology: quantum dots in bioimaging. Expert Rev Proteomics 4(4), 565–572 (2007)View ArticleGoogle Scholar
  5. K. Bonroy et al. Nanotechnology towards Biomedical Applications. NanobioEurope Congress (2007)Google Scholar
  6. J. Trekker, DBTG. Raj et al. Effect of the core size of monodisperse superparamagnetic nanoparticles on their relaxometric enhancing properties for MRI. 8th International Conference on Scientific and Clinical Applications of Magnetic Carriers, Rostock, 2010Google Scholar
  7. J. Trekker, DBTG. Raj et al. The synthesis of superparamagnetic nanoparticles towards MRI contrasts agents, DIMI/EMl meeting (2008) AbstractGoogle Scholar
  8. D.B. Thimiri Govinda Raj et al., A novel strategy for the comprehensive analysis of the biomolecular composition of isolated plasma membranes. Mol. Syst. Biol. 7, 541 (2011)View ArticleGoogle Scholar
  9. H.M. Mansour et al., Nanomedicine in pulmonary delivery. Int. J. Nanomed. 4, 299–319 (2009)View ArticleGoogle Scholar
  10. M.E. Davis, Z. Chen, Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. 7, 771–782 (2008)Google Scholar
  11. J.L. Brown et al., Composite scaffolds: bridging nanofiber and microsphere architectures to improve bioactivity of mechanically competent constructs. J. Biomed. Mater. Res. Part A 95, 1150–1158 (2010)View ArticleGoogle Scholar
  12. Ivo Iavicoli et al., Opportunities and challenges of nanotechnology in the green economy. Environ. Health 13, 78 (2014)View ArticleGoogle Scholar
  13. J. Trekker, DBTG. Raj et al. Synthesis of superparamagnetic nanoparticles for stem cell tracking, Nanobioeurope (2008) AbstractGoogle Scholar
  14. H. John, Phan et al., Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment. Trends. Biotechnol. 27(6), 350–358 (2009)View ArticleGoogle Scholar
  15. H.-S. Li, D.B. Stolz, G. Romero, Characterization of endocytic vesicles using magnetic microbeads coated with signalling ligands. Traffic 6, 324–334 (2005)View ArticleGoogle Scholar
  16. H. Lodish. The architecture of cells—molecular cell biology (‎2000)Google Scholar
  17. Arseny S. Kaprelyants, Dynamic spatial distribution of proteins in the cell. Trends. Biochem. Sci. 13(2), 43–46 (1988)View ArticleGoogle Scholar
  18. M. Sperandio et al., Glycosylation in immune cell trafficking. Immunol. Rev. 230(1), 97–113 (2009)View ArticleGoogle Scholar
  19. P. Goluszko, B. Nowicki, Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells. Infect. Immun. 73(12), 7791–7796 (2005)View ArticleGoogle Scholar
  20. L. Pelkmans et al., Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436, 78–86 (2005)View ArticleGoogle Scholar
  21. W.M. Rideout III et al., Nuclear cloning and epigenetic reprogramming of the genome. Science 293(5532), 1093–1098 (2001)View ArticleGoogle Scholar
  22. D.B. Thimiri Govinda Raj et al. Plasma membrane Isolation (2011) US Patent 8, 936,935Google Scholar
  23. G.R. Rosania et al., Visualizing chemical structure-subcellular localization relationships using fluorescent small molecules as probes of cellular transport. J. Cheminform 5, 44 (2013)View ArticleGoogle Scholar
  24. V. Collura, G. Boissy, From protein-protein complexes to interactomics. Subcell. Biochem. 43, 135–183 (2007)View ArticleGoogle Scholar
  25. A.R. Joyce, B.Ø. Palsson, The model organism as a system: integrating ‘omics’ data sets. Nat. Rev. Mol. Cell Biol. 7, 198–210 (2006)View ArticleGoogle Scholar
  26. Md Altaf-Ul-Amin, F.M. Afendi, S.K. Kiboi, S. Kanaya, Systems biology in the context of big data and networks. BioMed Res Int. 2014, 11 (2014). doi:10.1155/2014/428570 Google Scholar
  27. G. Raposo et al., B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183(3), 1161–1172 (1996)View ArticleGoogle Scholar
  28. J.Graham and J. R. Harris. Isolation and Functional Analysis of Organelles, in Cell Biology Protocols In: J. R. Harris, J. Graham and D. Rickwood eds, John Wiley & Sons, Ltd, Chichester, UK (2006)Google Scholar
  29. Ankur Jain et al., Single-molecule pull-down for studying protein interactions. Nat. Protoc. 7, 445–452 (2012)View ArticleGoogle Scholar
  30. T.H. Taylor et al., Analysis of individual mitochondria via fluorescent immunolabeling with anti-TOM22 antibodies. Anal. Bioanal. Chem. 406(6), 1683–1691 (2014)View ArticleGoogle Scholar
  31. C.P. Satori et al., Bioanalysis of eukaryotic organelles. Chem. Rev 113(4), 2733–2811 (2013)View ArticleGoogle Scholar
  32. Nowacek A et al. Methods for Isolation and Identification of Nanoparticle-Containing Subcellular Compartments. Methods. Mol. Biol. (Clifton NJ 991: 47–55) (2013)Google Scholar
  33. D. Josic, J.G. Clifton, Mammalian plasma membrane proteomics. Proteomics 7, 3010–3029 (2007)View ArticleGoogle Scholar
  34. Kim Y et al. Use of colloidal silica-beads for the isolation of cell-surface proteins for mass spectrometry-based proteomics. Methods. Mol. Biol. (Clifton, N.J.) 748: 227–241 (2011).Google Scholar
  35. Yingxin Zhao et al., Proteomic analysis of integral plasma membrane proteins. Anal. Chem. 76(7), 1817–1823 (2004)View ArticleGoogle Scholar
  36. J. Fahrer et al., C2-streptavidin mediates the delivery of biotin-conjugated tumor suppressor protein p53 into tumor cells. Bioconjug Chem. 24(4), 595–603 (2013)View ArticleGoogle Scholar
  37. Jason M. Kinchen, Kodi S. Ravichandran, Phagosome maturation: going through the acid test. Nat. Rev. Mol. Cell Biol. 9, 781–795 (2008)View ArticleGoogle Scholar
  38. J.P. Luzio et al., Lysosomes: fusion and function. Nat. Rev. Mol. Cell Biol. 8, 622–632 (2007)View ArticleGoogle Scholar
  39. L. Jet Phey, A. Gleeson, Macropinocytosis: an endocytic pathway for internalizing large gulps. Immunol. Cell Biol. 89, 836–843 (2011)View ArticleGoogle Scholar
  40. H.T. McMahon, Emmanuel Boucrot, Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 12, 517–533 (2011)View ArticleGoogle Scholar
  41. R. Ivan, Nabi and Phuong U. Le., Caveolae/raft-dependent endocytosis. J. Cell Biol. 161(4), 673–677 (2003)View ArticleGoogle Scholar
  42. J.K. Schweitzer, A.E. Sedgwick, C. D’Souza-Schorey, ARF6-mediated endocytic recycling impacts cell movement, cell division and lipid homeostasis. Semin. Cell Dev. Biol. 22(1), 39–47 (2011)View ArticleGoogle Scholar
  43. T.G. Iversen, N. Frerker, K. Sandvig, Uptake of ricinB-quantum dot nanoparticles by a macropinocytosis-like mechanism. J. Nanobiotechnol 10, 33 (2012)View ArticleGoogle Scholar
  44. H. Li, Z.M. Qian, Transferrin/transferrin receptor-mediated drug delivery. Med. Res. Rev. 22, 225–250 (2002)View ArticleGoogle Scholar
  45. Li H1, Qian ZM. Transferrin/transferrin receptor-mediated drug delivery. Med. Res. Rev. 22(3):225–50 (2002)Google Scholar
  46. Carcea, Ioana et al. Flotillin-Mediated Endocytic Events Dictate Cell-Type Specific Responses to Semaphorin 3A. J. Neurosci.  30.45: 15317–15329 (2010)Google Scholar
  47. Emily M. Plummer, Marianne Manchester, Endocytic uptake pathways utilized by CPMV nanoparticles. Mol. Pharm. 10(1), 26–32 (2013)View ArticleGoogle Scholar
  48. A. K. Haghi et al. Nanomaterials: Synthesis, Characterization, and Applications. Series: Advances in Nanoscience and Nanotechnology (2013) Apple Academic Press 296: 167 ISBN 9781926895192Google Scholar
  49. Alkilany, Alaaldin M. et al. Toxicity and Cellular Uptake of Gold Nanoparticles: What We Have Learned so Far? J. Nanoparticle Res. (2010) 12.7 2313–2333Google Scholar
  50. Yu, Faquan et al. “The Magnetophoretic Mobility and Superparamagnetism of Core-Shell Iron Oxide Nanoparticles with Dual Targeting and Imaging Functionality.” Biomaterials 31.22: 5842–5848 (2010)Google Scholar
  51. Barakat, Assem et al. One step synthesis of NiO Nanoparticles via solid-state thermal decomposition at low-temperature of novel aqua (2,9-Dimethyl-1,10-phenanthroline)NiCl2 complex. Int. J. Mol. Sci. 14.12 23941–23954 (2013)Google Scholar
  52. Puri, Anu et al., Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit. Rev. Ther. Drug. Carrier. Syst. 26(6), 523–580 (2009)View ArticleGoogle Scholar
  53. C. Xu, S. Shouheng, Superparamagnetic Nanoparticles as Targeted Probes for Diagnostic and Therapeutic Applications. Dalton Trans. 29, 5583–5591 (2009)View ArticleGoogle Scholar
  54. Boylan, Nicholas J. et al. Highly Compacted DNA Nanoparticles with Low MW PEG Coatings: in Vitro, ex Vivo and in Vivo Evaluation. Journal of Controlled Release 157.1 72–79 (2012)Google Scholar
  55. Adam D. Friedman, Sarah E. Claypool, Rihe Liu, The Smart Targeting of Nanoparticles. Curr. Pharm. Des. 19(35), 6315–6329 (2013)View ArticleGoogle Scholar
  56. Yu, Mi Kyung, Jinho Park, and Sangyong Jon. Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy. Theranostics 2.1 3–44 (2012)Google Scholar
  57. Thimiri Govinda Raj DB, Fluorescent Nano-switches for diagnostic application. Protoc. Exch. (2016). doi:10.1038/protex.2015.125 Google Scholar
  58. Deepak Balaji TG et al., Biarsenical nanoparticles for in vivo labeling, WO2013076159 (2013)Google Scholar
  59. Prijic, Sara et al. “Increased Cellular Uptake of Biocompatible Superparamagnetic Iron Oxide Nanoparticles into Malignant Cells by an External Magnetic Field.” The Journal of Membrane Biology 236.1 167–179 (2010)Google Scholar
  60. Baltazar, Gabriel C. et al. “Acidic Nanoparticles Are Trafficked to Lysosomes and Restore an Acidic Lysosomal pH and Degradative Function to Compromised ARPE-19 Cells.” PLoS. One. 7(12) e49635 (2012)Google Scholar
  61. Walling, Maureen A, Jennifer A Novak, and Jason R. E Shepard. “Quantum Dots for Live Cell and In Vivo Imaging.” Int. J. Mol. Sci. 10(2) 441–491 (2009)Google Scholar
  62. D.A. Richards et al., Effects of Wortmannin and Latrunculin A on slow endocytosis at the frog neuromuscular junction. J. Physiol. 557(Pt 1), 77–91 (2004)View ArticleGoogle Scholar
  63. Thimiri Govinda Raj, B. Deepak et al., A novel strategy for the comprehensive analysis of the biomolecular composition of isolated plasma membranes. Mol. Syst. Biol. 7, 541 (2011)Google Scholar
  64. R. Sannerud et al., Restricted location of PSEN2/g-secretase determines substrate specificity and generates an intracellular ab pool. Cell 166, 1–16 (2016)View ArticleGoogle Scholar
  65. Raghunath AT et al. Novel surface functionalized superparamagnetic nanoparticles with engineered cellular uptake as a means for intracellular omics. Mol. Biol. Cell. (2014), 25 2pGoogle Scholar
  66. DBTG Raj et al., Cellular uptake of superparamagnetic nanoparticles as a strategy to isolate and characterize endosomal compartments. Frontiers Annual meeting Leuven (2007) AbstractGoogle Scholar
  67. DBTG Raj et al., Development and application of SPMNPs for subcellular proteomics. International Conference for Micro and Nanotechnologies for BioScience (2008)Google Scholar
  68. DBTG Raj et al., Surface coating dependent selection of Superparamagnetic Nanoparticles for whole cell isolation. 8th International Conference on the Scientific and Clinical Applications of Magnetic carrier, Rostock 2010Google Scholar


© The Author(s) 2016